
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical demonstrates a robust growth trajectory, evidenced by approximately 13% year-over-year procedure growth, which was further bolstered by a 90 basis point increase predominantly in the U.S. market. The company reported an 11% rise in Ion utilization alongside a notable 21% growth in SP system utilization, supporting an expanding installed base of 995 and 377 systems, respectively, indicating increasing adoption and operational efficiency. Additionally, a slight increase in system average selling prices (ASPs) reflects the favorable market dynamics and demand for its advanced surgical solutions.
Bears say
The analysis reveals concerns regarding Intuitive Surgical's projected revenue growth, particularly with the downward pressure on average selling prices (ASPs) and a slower-than-expected adoption of the da Vinci system, notably the Dv5 model. Despite achieving growth in specific procedure areas such as benign general surgery, the overall revenue trajectory for instruments and accessories remains less reliant on the new system's adoption, indicating a potential weakness in sustaining revenue growth. Additionally, broader market challenges, such as a tough capital purchasing environment and increasing competition, further cast doubts on the company's ability to maintain its historical growth rates, suggesting caution for investors.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares